Research

Balance BTD-001 IH201:

A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple-Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults with Idiopathic Hypersomnia or Narcolepsy Type 2

Flamel REST-ON Trial CLFT218-1501:

A double-blind, randomized, placebo controlled, two arm multi-centre clinical trial to assess the efficacy and safety of a once nightly formulation of Sodium Oxybate CR (FT218) for the treatment of Excessive Daytime Sleepiness and Cataplexy in patients with Narcolepsy.